A

Agilent Technologies
154.55
-0.95 (-0.61%)
Upgrade to Real-Time
Afterhours (Closed)
154.55
Volume 991,903
Bid Price
Ask Price
News (2)
Day High 155.42

Low
112.52

52 Week Range

High
160.265

Day Low 152.735
Company Name Stock Ticker Symbol Market Type
Agilent Technologies A NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.95 -0.61% 154.55 20:00:00
Open Price Low Price High Price Close Price Prev Close
153.17 152.735 155.42 154.55 155.50
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
17,154 991,903 $ 154.05 $ 152,799,047 - 112.52 - 160.265
Last Trade Time Type Quantity Stock Price Currency
19:00:00 177,227 $ 154.55 USD

Period:

Draw Mode:

Agilent Technologies Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 45.76B 296.07M 295.29M $ 6.85B $ 1.29B 4.18 37.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 0.84 0.58% 12/30/22 55.47k 1.40%

more financials information »

Agilent Technologies News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical A Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week155.75157.31150.21153.841,453,051-1.20-0.77%
1 Month154.36159.59143.01154.021,275,5710.190.12%
3 Months147.12160.265142.16152.421,340,7777.435.05%
6 Months133.45160.265120.60141.041,366,13021.1015.81%
1 Year142.00160.265112.52132.931,646,74512.558.84%
3 Years83.29179.5761.63122.391,707,07971.2685.56%
5 Years70.86179.5760.4298.971,895,77383.69118.11%

Agilent Technologies Description

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.